IFNAR1 and Zika virus infectious disease: Relevant ZIKV infection models have been developed in mice either using Ifnar1 knock-out (KO) mice in which the IFNAR receptor to IFN-I has been inactivated [10,11], or by blocking this receptor using a monoclonal antibody targeting the IFNAR1 receptor subunit (MAR1-5A3 [12]).